Health  Vol.7 No.5 , May 2015
Prostate Cancer’s Molecular Imaging by Targeting Based Nanoparticles: An Overview
Abstract: Today nanoparticles based drug delivery or imaging agents are extremely being investigated as a very powerful tool in early diagnostics or treatment of different kinds of cancers including prostate malignancies. Among the diverse developing nanomaterials, biocompatible biodegradable dendrimers and chitosan or PLGA (Poly Lactic-co-Glycolic Acid) derivatives are more considered due to their safer profiles. As a result, finding novel prostate imaging agents based on nano sized structures would be of high global interest which will be further discussed in this review.
Cite this paper: Heidari, H. , Fordoei, A. , Saffary, M. and Ardestani, M. (2015) Prostate Cancer’s Molecular Imaging by Targeting Based Nanoparticles: An Overview. Health, 7, 580-588. doi: 10.4236/health.2015.75069.

[1]   Lin, W., et al. (2009) Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging. MRS Bulletin, 34, 441-448.

[2]   Sun, C., et al. (2008) Magnetic Nanoparticles in MR Imaging and Drug Delivery. Advanced Drug Delivery Reviews, 60, 1252-1265.

[3]   Reddy, J.M. and Prasad, V. (2005) Step by Step MRI. 3rd Edition, Jaypee Brothers, New Delhi, 124-125.

[4]   Sasaki, M., et al. (2005) Enhancement Effects and Relaxivities of Gadolinium-DTPA at 1.5 versus 3 Tesla: A Phantom Study. Magnetic Resonance in Medical Sciences, 4, 145-149.

[5]   Raymond, K.N. and Pierre, V.C. (2005) Next Generation, High Relaxivity Gadolinium MRI Agents. Bioconjugate Chemistry, 16, 3-8.

[6]   Moriggi, L.C. (2009) Gold Nanoparticles Functionalized with Gadolinium Chelates as High-Relaxivity MRI Contrast Agents. Journal of the American Chemical Society, 131, 10828-10829.

[7]   Wai-Yan, C. and Wing-Tak, W. (2007) Small Molecular Gadolinium (III) Complexes as MRI Contrast Agents for Diagnostic Imaging. Coordination Chemistry Reviews, 251, 2428-2451.

[8]   Shahbazi-Gahrouei, D., et al. (2001) In Vivo Studies of Gd-DTPA-Monoclonal Antibody and Gd-Porphyrins: Potential Magnetic Resonance Imaging Contrast Agents for Melanoma. Journal of Magnetic Resonance Imaging, 14, 169-174.

[9]   Amanluo, M., et al. (2011) Gd3+-DTPA-DG: Novel Nanosized Dual Anticancer and Molecular Imaging Agent. International Journal of Nano-medicine, 6, 747-763.

[10]   Ananta, J.S., et al. (2010) Geometrical Confinement of Gadolinium-Based Contrast Agents in Nanoporous Particles Enhances T1 Contrast. Nature Nanotechnology, 5, 815-821.

[11]   Shahbazi-Gahrouei, D., Roufeh, M. and Tavakoli, M.B. (2006) Gadolinium-Diethylenetriaminepenta-Acetic Acid Con- jugated with Monoclonal Antibody C595 as New Magnetic Resonance Imaging Contrast Agents for Breast Cancer (MCF-7) Detection. Iranian Biomedical Journal, 10, 209-213.

[12]   McNeil, S.E. (2005) Nanotechnology for the Biologist. Journal of Leukocyte Biology, 78, 585-594.

[13]   Dubey, P.K., Mishra, V., Jain, S., Mahor, S. and Vyas, S.P. (2004) Liposomes Modified with Cyclic RGD Peptide for Tumor Targeting. Journal of Drug Targeting, 12, 257-264.

[14]   Vandamme, T.F. and Brobeck, L. (2005) Poly(Amidoamine) Dendrimers as Ophthalmic Vehicles for Ocular Delivery of Pilocarpine Nitrate and Tropicamide. Journal of Controlled Release, 102, 23-38.

[15]   Yang, W., Barth, R.F., Wu, G., Bandyopadhyaya, A.K., Thirumamagal, B.T., Tjarks, W., Binns, P.J., Riley, K., Patel, H., Coderre, J.A., Ciesielski, M.J. and Fenstermaker, R.A. (2004) Boronated Epidermal Growth Factor as a Delivery Agent for Neutron Capture Therapy of EGF Receptor-Positive Gliomas. Applied Radiation and Isotopes, 61, 981-985.

[16]   Hamedy, S., Haddadi, A., Hung, R.W. and Lavasanifar, A. (2011) Targeting Dendritic Cells with Nano-Particulate PLGA Cancer Vaccine Formulation. Advance Drug Delivery Reviews, 63, 943-955.

[17]   Hasan, W., Chu, K., Gullapalli, A., Dunn, S.S., Enlow, E.M., Luft, J.C., Tian, S.M., Napier, M.E., Pohlhaus, P.D., Rolland, J.P. and DeSimone, J.M.(2012). Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer. Nano Letters, 12, 287-292.

[18]   Burtea, C., Laurent, S., Colet, J.M., Vander, E.L. and Muller, R.N. (2003) Development of New Glycosylated Derivatives of Gadolinium Diethylenetriaminepentaacetic for Magnetic Resonance Angiography. Investigative Radiology, 38, 320-333.

[19]   Ganapathy, V., Thangaraju, M. and Prasad, P.D. (2009) Nutrient Transporters in Cancer: Relevance to Warburg Hypothesis and Beyond. Pharmacology & Therapeutics, 121, 29-40.

[20]   Ardestani, M.S., et al. (2010) Novel and Facile Methods for the Synthesis of DTPA-Mono-Amide: A New Completely Revised Strategy in Radiopharmaceutical Chemistry. Journal of Radioanalytical and Nuclear Chemistry, 283, 447-455.

[21]   Shen, Z.Y., Li, Y., Kohama, K., Oneill, B. and Bi, J.X. (2011) Improved Drug Targeting of Cancer Cells by Utilizing Actively Targetable Folic Acid-Conjugated Albumin Nanospheres. Pharmacological Research, 63, 51-58.

[22]   Li, L.L., Yin, Q., Cheng, J.J. and Lu, Y. (2012) Polyvalent Mesoporous Silica Nanoparticle-Aptamer Bioconjugates Target Breast Cancer Cells. Advanced Healthcare Materials, 1, 567-572.

[23]   de la Fuente, J.M. and Penadés, S. (2006) Glyconanoparticles: Types, Synthesis and Applications in Glycoscience, Biomedicine and Material Science. Biochimica et Biophysica Acta, 1760, 636-651.

[24]   Veerapandian, M. and Yun, K. (2010) Synthesis of Silver Nanoclusters and Functionalization with Glucosamine for Glyconanoparticles. Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry, 40, 56-64.

[25]   Rojo, J., et al. (2004) Gold Glyconanoparticles as New Tools in Antiadhesive Therapy. ChemBioChem, 5, 291-297.

[26]   Mirzaei, M., et al. (2012) Novel Nanosized Gd3+-ALGD-G2-C595: In Vivo Dual Selective MUC-1 Positive Tumor Molecular MR Imaging and Therapeutic Agent. Journal of Nanomedicine Nanotechnology, 3, 1-6.

[27]   Mirzaei, M., et al. (2012) Gd3+-Anionic Linear Globular Dendrimer-G2-C595 a Dual Novel Nanoprobe for MR Imaging and Therapeutic Agent: An in Vitro Study. Biomolecular Research & Therapeutics, 1, 103.

[28]   Bayly, S.R., Fisher, C.L., Storr, T., Adam, M.J. and Orvig, C. (2004) Carbohydrate Conjugates for Molecular Imaging and Radiotherapy: 99mTc(I) and 186Re(I) Tricarbonyl Complexes of N-(2’-Hydroxybenzyl)-2-amino-2-deoxy-D-glucose. Bioconjugate Chemistry, 15, 923-926.

[29]   Mehravi, B., et al. (2013) Facile Conjugation of Glucosamine on Gd3+ Based Nanoporous Silica Using Heterobifunctional Crosslinker (ANB-NOS) for Cancer Cell Imaging. International Journal of Nanomedicine, 8, 3383-3394.

[30]   Mehravi, B., et al. (2013) Cellular Uptake and Imaging Studies of Glycosylated Silica Nanoprobe (GSN) in Human Colon Adenocarcinoma (HT 29 Cell Line). International Journal of Nanomedicine, 8, 3209-3216.

[31]   Schibli, R., Dumas, C., et al. (2005) Synthesis and in Vitro Characterization of Organometallic Rhenium and Technetium Glucose Complexes against Glut 1 and Hexokinase. Bioconjugate Chemistry, 16, 105-112.

[32]   Taylor, R.A., Phelan, P.E., Otanicar, T.P., Adrian, R. and Prasher, R. (2011) Nanofluid Optical Property Characterization: Towards Efficient Direct Absorption Solar Collectors. Nanoscale Research Letters, 6, 225.

[33]   Ardestani, M.S. (2010) Potential Opponent for 18FDG: Gd3+-DTPA-DG: A New Synthetic MRI Contrast Agent. Iranian Journal of Radiology, 7, 56.

[34]   Mehravi, B., et al. (2014) Breast Cancer Cells Imaging By Targeting Methionine Transporters with Gadolinium-Based Nanoprobe. Molecular Imaging and Biology, 16, 519-528.

[35]   Darvish, M.T., et al. (2013) Gd3+-DTPA-Meglumine-Anionic Linear Globular GI: Novel Nanosized Law Toxic Tumor Molecular MR Imaging Agent. ISRN Pharmaceutics, 2013, Article ID: 378452.

[36]   Dabbs, D.M. and Aksay, I.A. (2000) Self-Assembled Ceramics Produced by Complex-Fluid Templation. Annual Review of Physical Chemistry, 51, 601-622.

[37]   Buffat, Ph. and Borel, J.-P. (1976) Size Effect on the Melting Temperature of Gold Particles. Physical Review A, 13, 2287.

[38]   Carretero, M.I. and Pozo, M. (2009) Clay and Non-Clay Minerals in the Pharmaceutical Industry: Part I. Excipients and Medical Applications. Applied Clay Science, 46, 73-80.

[39]   Park, J., Cho, W., Park, H.J., Cha, K.H., Ha, D.C., Choi, Y.W., Lee, H.Y., Cho, S.H. and Hwang, S.J. (2013) Biodistribution of Newly Synthesized PHEA-Based Polymer-Coated SPION in Sprague Dawley Rats as Magnetic Resonance Contrast Agent. International Journal of Nanomedicine, 8, 4077-4089.

[40]   Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A.K., Thomas, T., Mule, J. and Baker Jr., J.R. (2002) Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells through the Folate Receptor. Pharmaceutical Research, 19, 1310-1316.

[41]   Dubey, P.K., Mishra, V., Jain, S., Mahor, S. and Vyas, S.P. (2004) Liposomes Modified with Cyclic RGD Peptide for Tumor Targeting. Journal of Drug Targeting, 12, 257-264.

[42]   Reszka, R.C., Jacobs, A. and Voges, J. (2005) Lipo-some-Mediated Suicide Gene Therapy in Humans. Methods in Enzymology, 391, 200-208.

[43]   ten Hagen, T.L. (2005) Liposomal Cytokines in the Treatment of Infectious Diseases and Cancer. Methods in Enzymology, 391, 125-145.

[44]   Thamake, S.I., Raut, S.L., Gryczynski, Z., Ranjan, A.P. and Vishwanatha, J.K. (2012) Alendronate Coated Poly-Lactic-Co-Glycolic Acid (PLGA) Active Targeting of Metastatic Breast Cancer. Biomaterials, 33, 7164-7173.

[45]   Dhar, S., Gu, F.X., Langer, R., Farokhzade, O.C. and Lippard, S.J. (2008) Targeted Delivery of Cisplatin to Prostate Cancer Cells by Aptamer Functionalized Pt(IV) Prodrug-PLGA-PET Nanoparticles. Proceedings of the National Academy of Sciences, 105, 17356-17361.

[46]   Yhee, J.Y., Koo, H., Lee, D.E., Choi, K. and Kwon, I.C. (2011). Multifunctional Chitosan Nanoparticles for Tumor Imaging and Therapy. Advances in Polymer Science, 243, 139-161.

[47]   Du, H.L., Cai, X.Q. and Zhai, G.X. (2013) Advances in the Targeting Molecules Modified Chitosan-Based Nanoformu lations. Current Drug Targets, 14, 1034-1052.

[48]   Bergey, E.J., Levy, L., Wang, X.P., Krebs, L.J., Lal, M., Kim, K.S., Pakatchi, S., Liebow, C. and Prasad, P.N. (2002) DC Magnetic Field Induced Magnetocytolysis of Cancer Cells Targeted by LH-RH Magnetic Nanoparticles in Vitro. Biomedical Microdevices, 4, 293-299.

[49]   Nurunnabi, Md., Cho, K.J., Choi, J.S., Huh, Y.M. and Lee, Y.-K. (2010) Targeted Near-IR QDs-Loaded Micelles for Cancer Therapy and Imaging. Biomaterials, 31, 5436-5444.

[50]   Xiao, Y.L., Hong, H., Javadi, A., Engle, J.W., Xu, W.J., Yang, Y.N., Zhang, Y. and Bamhart, T.E. (2012) Multifunctional Unimolecular Micelles for Cancer-Targeted Drug Delivery and Positron Emission Tomography Imaging. Biomaterials, 33, 3071-3082.

[51]   Bailey, D.L., Townsend, D.W., Valk, P.E. and Maisey, M.N. (2005) Positron Emission Tomography: Basic Sciences. Springer-Verlag, Secaucus.

[52]   Gubin, S.P. (2009) Magnetic Nanoparticles. Wiley-VCH, Weinheim.

[53]   U.S. Food and Drug Administration (2014) Sunscreen.

[54]   Mitchnick, M.A., Fairhurst, D. and Pinnell, S.R. (1999) Microfine Zinc Oxide (Z-Cote) as a Photostable UVA/UVB Sunblock Agent. Journal of the American Academy of Dermatology, 40, 85-90.